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Embryonal tumors are a group of malignant neoplasms
that most commonly affect the pediatric population.
Embryonal tumor with abundant neuropil and true
rosettes is a recently recognized rare tumor. It is composed
of neurocytes and undifferentiated neuroepithelial cells
arranged in clusters, cords and several types of rosettes in a
prominent neuropil-rich background. We describe a new
case of this tumor. The patient, a 24-month-old female
infant, was referred to the Meyer Children’s Hospital with
a history of right brachio-crural deficit associated with
occasional episodes of headache and vomiting. Computed
tomography scan and MRI revealed a large bihemispheric
mass. The patient underwent two consecutive surgeries.
The resultant surgical resection of the tumor was macro-
scopically complete. The postoperative period was
uneventful. On light microscopy the tumor showed a com-
posite morphology: embryonal tumor with abundant neu-
ropil and true rosettes (specimen from the first surgery);
medulloepithelioma with mesenchymal and epithelial
areas (specimen from the second surgery). The immuno-
histochemistry evidenced the heterogeneous (neuronal,
mesenchymal and epithelial) immunoprofile of tumoral
cells. By real-time polymerase chain reaction (RT-PCR),
the PTEN gene expression in the tumor was lower than in
the five non-neoplastic brain tissues used as control. Muta-
tion analysis did not show any variation in INI-1 and
PTEN sequence while P53 analysis showed the presence of
homozygote P72R variation. Fluorescent in situ hybridiza-
tion analysis showed polysomy of chromosome 2 while
amplification of N-MYC was not detected. Owing to the
rarity of embryonal tumor with abundant neuropil and true
rosettes, each new case should be recorded to produce a
better clinical, pathological and molecular characterization
of this lesion.
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INTRODUCTION
Embryonal tumors are a group of malignant neoplasms
that most commonly affect the pediatric population. The
latest edition of the World Health Organization (WHO)
classification of CNS tumors distinguishes three main
histological entities: medulloblastoma and its variants
(desmoplastic medulloblastoma, medulloblastoma with
extensive nodularity, anaplastic medulloblastoma and large
cell medulloblastoma), CNS primitive neuroectodermal
Correspondence: Anna Maria Buccoliero, MD, PhD, Department of
Biomedicine, Careggi Hospital, Florence,V.le GB. Morgagni, 85, 50134
Florence, Italy. Email: ambuccoliero@unifi.it
Received 31 March 2009; revised and accepted 13 May 2009.
Neuropathology 2009 doi:10.1111/j.1440-1789.2009.01040.x
© 2009 Japanese Society of Neuropathology
tumor (PNET) ant its variants (CNS neuroblastoma, CNS
ganglioneuroblastoma, medulloepithelioma and ependy-
moblastoma) and atypical teratoid/rhabdoid tumor (AT/
RT).1
In 2000, Eberhart et al. described a rare pediatric
embryonal tumor called pediatric neuroblastic tumor con-
taining abundant neuropil and true rosettes.2 This tumor
combines the features of neuroblastoma and ependymo-
blastoma. It is morphologically characterized by undif-
ferentiated neuroepithelial cells arranged in clusters,
cords and several types of rosettes (i.e. ependymoblastic,
Homer-Wright, Flexner-Wintersteiner and perivascular) in
a neuropil-rich background. Although a number of such
cases have been described, this entity has not been consid-
ered a distinct neoplasm (it has been believed to be just
“an unusual PNET”) in the WHO classification of CNS
tumors and also its appropriate nomenclature remains to
be decided (pediatric/embryonal/neuroblastic tumor with
abundant neuropil and true rosettes).1
Actually, it is sometimes complex to categorize the
tumors, particularly in case of neoplasms showing compos-
ite morphology.
Herein, we describe a case of embryonal tumor with
abundant neuropil and true rosettes showing features
of medulloepithelioma and areas of mesenchymal and
epithelial differentiation. The morphological, immuno-
histochemical, ultrastructural and molecular (P53, PTEN,
INI-1, N-MYC) traits of this tumor are described.
CASE REPORT
A 24-month-old female infant was referred to Meyer Chil-
dren’s Hospital with a history of right brachio-crural deficit
associated with occasional episodes of headache and vom-
iting. A CT scan revealed a large bihemyspheric mass with
calcifications. MRI was performed as well and this docu-
mented a lesion enhanced by gadolinium with solid and
cystic components (Fig. 1). Due to the dimensions of the
tumor and its rich vascularisation, the patient underwent
two consecutive surgeries spaced by 1 week (left parieto-
occipital and right parieto-occipital surgical approaches).
The resultant surgical resection of the tumor was macro-
scopically complete. The postoperative period was
uneventful with a good motor function recovery. Spinal
imaging and CSF cytology were negative. Thus, the patient
was treated according to the institutional protocol for
infant CNS PNET which consists of high doses of chemo-
therapy and autologous stem cell rescue followed by tai-
lored radiotherapy. Her treatment course passed without
complication and she was discharged without relevant
neurologic signs. As of the patient’s last follow-up at
10 months, she was doing well with a Karnofsky perfor-
mance status score of 80%.
METHODS
From the fresh surgical specimens of each surgery we
selected a fragment macroscopically representative of the
tumor. Successively, we cut it in half: from one half several
5-mm frozen sections stained with HE were obtained to
verify the adequacy of the specimen selected for molecular
studies (presence of pathological tissue only); the other
half was immersed in RNAlaterTM (QIAGEN, Valencia,
CA, US) and kept overnight at +4°C and finally stored
at -80°C until molecular analysis (RT-PCR and gene
sequencing). Total RNA was isolated with 6100 Nucleic
Acid PrepStation and 500 ng of RNA were subject to
reverse transcription to cDNA using High Capacity cDNA
Archive Kit (Applied Biosystems, Foster City, CA, US).
Real-time quantitative PCR amplification for PTEN gene
was routinely executed using the ABI PRISM 7000
Sequence Detector System (Applied Biosystems). PCR
products for PTEN were detected using gene-specific
primers and probes labeled with reporter day FAM (Assay
on Demand, Applied Biosystems). A series of five non-
neoplastic brain tissues were used as control samples.
gAPDH was used as endogenous control gene for normal-
ization. For gene sequencing, genomic DNA from tumor
tissues of specimens from both surgeries, were extracted
with QIAamp DNA Kit (QIAGEN, Milan, Italy) according
to the manufacture’s protocol. DNA concentrations were
determined using spectrophotometer GeneQuant II (Phar-
macia, Cambridge, UK). The complete coding sequence
and flanking exon-intron borders of the INI-1 (exons 1–9),
PTEN (exons 1–9) and P53 (exons 2–11) genes were inves-
tigated by direct sequencing. PCR primers are available
upon request. PCR products were sequenced by ABI
Prism® 3130 Genetic Analyzer (Applied Biosystems).
Several additional fresh fragments from the first surgery
macroscopically representative of the tumor were fixed in
2.5% glutaraldehyde and processed for electron micros-
copy by conventional method (ultrathin sections were
stained using uranyl acetate and lead citrate, then observed
with a Philips 410 LS transmission electron microscope).
The remaining tumor specimens from both surgeries
were routinely formalin-fixed and paraffin-embedded. His-
tological sections were stained with HE for histomorpho-
logical evaluation. Further 5-mm sections of the most
representative sample were mounted on electrostatic slides
and used for the standard immunohistochemical and dual
color fluorescence in situ hybridization (FISH) analysis.
Immunohistochemical studies were performed using the
standard streptavidin-biotin technique and commercially
available reagents. The primary antibodies used were
against: smooth muscle actin (clone 1A4, Cell Marque Cor-
poration, Rocklin, CA, US), muscle-specific actin (clone
HHF35, Cell Marque), synaptophysin (SP, polyclonal, Cell
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Marque), neurofilaments (NF, clone 2F11, Cell Marque),
desmin (clone DE-R-11,Ventana Medical Systems,Tucson,
AZ, US), cytokeratins (clone AE1, Ventana; clone AE3,
Ventana; clone CAM 5.2, BD Biosciences, Becton Dickin-
son, San Jose, CA, US), p53 (clone DO-7,Ventana), BAF47
(INI-1, clone 25/BAF47, BD Biosciences) and Ki-67 (clone
Mib-1, Dako A/S, Glostrup, Denmark).
For detection of the N-MYC oncogene, located at 2p24
region, we used the LSI® N-MYC (2p24)/ CEP® 2 (2p11.1-
q11.1) Dual Color Probe Set (Abbott Molecular Inc.,
Abbott Park, IL, USA).The LSI N-MYC (2p24) probe was
used to detect the N-MYC oncogene copy number to
assess the amplification status of the N-MYC gene. The
CEP 2 probe serves as a control for the ploidy level for
chromosome 2. For each specimen, signals were enumer-
ated in 100 non-overlapping nuclei. Specimens were con-
sidered amplified when they demonstrated a N-MYC/CEP
2 ratio greater than 2.
RESULTS
On light microscopical examination, the tumor specimens
from the two surgeries were very different. Microscopic
sections from the first surgery revealed wide neuropil-rich
areas containing neurocytic elements and hypercellular
regions composed by small cells with round-to-oval nuclei,
Fig. 1 (a) MRI axial T2-weighted image
shows a large tumor involving the left
parietal and occipital lobe and extending
over the midline to the upper part of the
controlateral cerebral hemisphere. The
MRI signal is iso-hyperintense with small
areas of hyperintensity. (b) MRI axial
T1-weighted gadolinium-enhanced image
shows the disomogeneous contrast
medium-enhancing and iso-hyperintense
signal of the tumor. (c) MRI coronal
T1-weighted gadolinium-enhanced image
shows the midline shift on the lower part
of parieto-occipital lobe without invasion
of the lower part of the controlateral cere-
bral hemisphere, with disomogeneous
contrast-enhancement as well as MR
signal that appear iso-hyperintense.
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scanty cytoplasm and indistinct cell borders (Fig. 2). The
lesion showed numerous rosettes (perivascular, ependymo-
blastic and Homer-Wright) (Fig. 3). Mitotic figures and
prominent apoptotic bodies were frequently observed in
highly cellular areas and in the rosettes. Necrosis and hem-
orrhage were present. The tumor border was sharply
demarcated from the non-neoplastic nervous parenchyma.
By immunohistochemistry, there was a diffuse positivity to
SP (Fig. 4). Neuropil-rich areas were positive to NF. The
undifferentiated cells (hypercellular regions and rosettes)
overexpressed p53 protein. The Mib-1 proliferation index
ranged from 3% in the neuropil-rich areas to 80% in the
areas of high cellularity and in the rosettes.The tumor cells
exhibited diffuse INI-1 nuclear staining. The sample for
ultrastructural analysis included areas from the neuropil-
rich regions, and showed neoplastic cells with round, often
indented nuclei with clumped chromatin, and cytoplasm
containing few organelles and abundant glycogen. Inter-
spersed between neoplastic cells there were numerous pro-
cesses of varying diameter, which contained intermediate
filaments, microtubules, and few putative neurosecretory
granules (Fig. 5).
Microscopic sections from the second surgery revealed
a composite tumor without neuropil-rich areas.There were
hypercellular undifferentiated zones composed by small
cells mainly organized in a perivascular fashion, neural
a
b
Fig. 2 Microscopic sections from the first surgery revealed
neuropil-rich areas containing neurocytic elements (a) and hyper-
cellular regions composed by small undifferentiated cells (b). HE;
original magnification: (a) ¥100, (b) ¥200.
Fig. 3 The lesion (specimen from first
surgery) showed numerous rosettes, i.e.
ependymoblastic (a) and Homer-Wright
(b). HE; original magnification: (a,b) ¥200.
Fig. 4 Immunoistochemistry (specimen from first surgery):
diffuse synaptophysin positivity. original magnification: ¥100.
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tube-like structures delimited by pseudo-stratified cylindri-
cal cells with a pseudo-papillary and trabecular arrange-
ment and sarcomatoid areas composed by elongated cells
containing medium-sized nests of epithelioid cells (Fig. 6).
Analogously to the specimens from the first surgery, there
were necrotic-hemorrhagic areas and the tumor border
was sharply demarcated. By immunohistochemistry, the
undifferentiated areas were NF-positive, the neural tube-
like structures were NF- and p53-positive, the sarcomatoid
areas were focally actin-positive and the epithelioid nests
were AE1- and CAM 5.2-positive (Fig. 7). The Mib-1 pro-
liferation index ranged from 10% in the sarcomatoid and
epithelioid areas to 80% in areas of high cellularity and in
the neural-tube like structures. The tumor cells exhibited
diffuse INI-1 nuclear staining.
Morphologic and ultrastructural features along with
immunohistochemical results were consistent with the
diagnosis of embryonal tumor with abundant neuropil and
true rosettes showing features of medulloepithelioma and
areas of mesenchymal and epithelial differentiation.
By RT-PCR, the gene expression of PTEN in the first
and in the second surgical specimens was lower than the
PTEN expression in non-neoplastic brain tissues (respec-
tively 0.12 times and 1.73 times) using gAPDH as control
gene for normalization.
Mutation analysis did not show any variation in INI-1
and PTEN sequences while P53 analysis showed the pres-
ence of homozygote P72R variation in both specimens
(Fig. 8).
Fig. 5 Processes of varying diameter, containing intermediate
filaments and few putative neurosecretory vescicles (asterisk).
Original magnification ¥14 000.
Fig. 6 Microscopic sections from the
second surgery revealed a composite
tumor: neural tube-like structures delim-
ited by pseudo-stratified cylindrical cells
(a,b), sarcomatoid areas composed by
elongated cells containing medium-sized
nests of epithelioid cells (a,c) and hyper-
cellular undifferentiated zones composed
by small cells mainly organized in a
perivascular fashion (d). HE; original nag-
nification: (a,b,d) ¥100; (c) ¥200.
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Fluorescent in situ hybridization analysis showed poly-
somy of chromosome 2 in both samples, while amplifica-
tion of N-MYC was not detected (Fig. 9).
DISCUSSION
Embryonal brain tumors are unusual neoplasms which are
more frequent in the pediatric age-group. On the basis of
their distinctive morphological, immunohistochemical, his-
togenetic, and molecular characteristics, they are classified
as medulloblastoma, CNS PNET and AT/RT. All embryo-
nal tumors are categorized as WHO grade IV due to the
aggressive biological behavior.1 Medulloblastomas are the
most common and constitute ª 20% of all primary pediat-
ric brain tumors.3 Embryonal tumor with abundant neuro-
pil and true rosettes is a recently recognized embryonal
tumor which in the past was frequently diagnosed as
ependymoblastoma due to the presence of endymoblastic
rosettes.4 Recently a number of cases of this tumor have
been referred, confirming the conviction that it is a distinct
embryonal tumor.5 All reported cases have been in very
young children with a female predominance. In the major-
ity of the cases the lesions were large and supratentorial.
Fig. 7 Immunoistochemistry (specimen
from second surgery): NF- (a) and p53- (d)
positive neural tube-like structures; focal
positivity to HHF35 in sarcomatoid areas
(b); Cam 5.2-positive epithelioid nests (c).
Original magnification: (a,b) ¥100; (c)
¥200; (d) ¥50.
Specimen from first 
surgery 
Specimen from second 
surgery 
Fig. 8 P53 mutation analysis showed the presence of homozy-
gote P72R variation in both lesions.
Fig. 9 Dual-color fluorescent in situ hybridization analysis
(sample from first surgery) showing polysomy of chromosome 2
(orange signals); amplification of N-MYC (green signals) was not
detected.
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The outcome was commonly poor despite intensive treat-
ments.4,6 Our case is typical with regard to age, sex, size and
localization, whereas it is extraordinary with regard to its
singular composite morphology: embryonal tumor with
abundant neuropil and true rosettes and medulloepithe-
lioma. Indeed, contrary to the areas of epithelial and mes-
enchymal differentiation which are sometimes described in
this tumor,5 the observation of medulloepitheliomatous
areas has never been reported. Actually, it is well known as
embryonal tumor, such as other neuroepithelial tumors
may be polyphenotypic as a result of metaplastic-like pro-
cesses or as consequence of divergent differentiation of
tumoral stem cells.7,8
Due to the frequent presence in the embryonal tumor
with abundant neuropil and true rosettes of ependymo-
mastic rosettes, ependymoblastoma is the main differential
diagnosis of this tumor and vice versa. In regard to this
Judkins and Ellison reviewed a group of 14 ependymoblas-
tomas diagnosed in their institution and stated that the
initial diagnosis of ependymoblastoma was never con-
firmed. In particular eight (57%) of these 14 ependymo-
blastomas were reclassified as embryonal tumor with
abundant neuropil and true rosettes.4
From a molecular point of view, we did not document in
our case N-MYC amplification (detected in more aggres-
sive neuroblastomas and in large cell/anaplastic medullo-
blastomas) and mutations of the INI-1 (typical of AT/RT)
gene.3,9–11 This last conclusion was also confirmed by the
diffuse INI-1 nuclear immunostaining. The FISH analysis
showed case extra copies of chromosome 2 in our case.
These results are in agreement to that reported by Fuller et
al.5,12,13 Interestingly, it has been suggested that the chro-
mosome 2 polysomy could differentiate this tumor from
other embryonal tumors.5,12,13 Through gene sequencing,
we identified a variation in the P53 gene in both surgical
specimens. P72 variant is located in a proline-rich domain
of P53 gene14 and it produces marked changes in the
primary structure and biological activity of p53. Epidemio-
logical studies have shown that differences in the polymor-
phism may affect the susceptibility of an individual to
different tumors, even if at present there are still several
controversial results in the literature.15–17 Interestingly,
immunohistochemical analysis evidenced a positive
nuclear reaction at the level of the undifferentiated cells
and in medulloepithelioma areas, whereas the neurocytic-
like cells localized in the neuropil-rich zones as well the
mesenchymal and epithelial areas, were completely nega-
tive. Based on the observation that the immunodetection
of p53 correspond to the P53 gene mutation, we
could suppose a biclonal molecular profile in our lesion
(undifferentiated and medulloepitheliomatous areas vs.
neuropil-rich, mesenchymal and epithelial areas). PTEN
gene is one of the most commonly lost tumor suppressors
in human cancer. In CNS tumors, genetic inactivation of
PTEN frequently occurs in glioblastoma.18 In our case,
despite PTEN expression as evaluated by RT-PCR,
resulted slightly lower than non neoplastic tissue, gene
sequencing did not provide evidence of PTEN alterations.
Owing to the rarity of embryonal tumor with abundant
neuropil and true rosettes, each new case should be
recorded to produce a better clinical, pathological and
molecular characterization of this lesion.
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